United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar MarkP28665 (37.95) Submitted: 12/21/2011 8:32:37 PM : Outperform Start Price: $45.04 UTHR Score: -8.19

Promising pipeline

Featured Broker Partners


Advertisement